Charles Schwab’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-224	Closed	-$67.1K	–	3650
2024 Q1	$67.1K	Hold	224	–	–	﹤0.01%	3342
2023 Q4	$52.8K	Hold	224	–	–	﹤0.01%	3400
2023 Q3	$33.5K	Hold	224	–	–	﹤0.01%	3450
2023 Q2	$38.9K	Hold	224	–	–	﹤0.01%	3455
2023 Q1	$28.2K	Hold	224	–	–	﹤0.01%	3459
2022 Q4	$67.8K	Buy	+224	New	+$33K	﹤0.01%	3305
2022 Q3	–	Sell	-604	Closed	-$37K	–	3525
2022 Q2	$37K	Buy	+604	New	+$44.7K	﹤0.01%	3434
2022 Q1	–	Sell	-349	Closed	-$51K	–	3598
2021 Q4	$51K	Hold	349	–	–	﹤0.01%	3514
2021 Q3	$77K	Buy	349 +235	+206%	+$49.8K	﹤0.01%	3408
2021 Q2	$27K	Sell	114 -763	-87%	-$194K	﹤0.01%	3408
2021 Q1	$264K	Hold	877	–	–	﹤0.01%	3275
2020 Q4	$330K	Hold	877	–	–	﹤0.01%	3120
2020 Q3	$270K	Sell	877 -5	-0.6%	-$1.91K	﹤0.01%	3064
2020 Q2	$332K	Buy	882 +64	+8%	+$18.1K	﹤0.01%	2996
2020 Q1	$187K	Hold	818	–	–	﹤0.01%	3026
2019 Q4	$433K	Hold	818	–	–	﹤0.01%	2878
2019 Q3	$353K	Hold	818	–	–	﹤0.01%	2926
2019 Q2	$975K	Buy	818 +32	+4%	+$38.3K	﹤0.01%	2584
2019 Q1	$980K	Buy	786 +22	+3%	+$25.2K	﹤0.01%	2558
2018 Q4	$724K	Hold	764	–	–	﹤0.01%	2637
2018 Q3	$1.1M	Buy	764 +24	+3%	+$36.3K	﹤0.01%	2592
2018 Q2	$1.19M	Buy	+740	New	+$1.27M	﹤0.01%	2535
2017 Q2	–	Sell	-196	Closed	-$107K	–	3115
2017 Q1	$107K	Hold	196	–	–	﹤0.01%	3009
2016 Q4	$120K	Hold	196	–	–	﹤0.01%	3031
2016 Q3	$141K	Hold	196	–	–	﹤0.01%	2981
2016 Q2	$143K	Buy	+196	New	+$135K	﹤0.01%	3016